2024 Internal Medicine Comprehensive Update (On-Demand)
-
Register
- Non-member - $995
- Member - $795
- Resident/Fellow - $495
- Student - Free!
2024 Internal Medicine Comprehensive Update (On-Demand)
The ACOI 2024 Internal Medicine Comprehensive Update will help you to maintain best-practice knowledge and skills in all areas of practice of internal medicine and subspecialty topics.
CME Credit Available:
This activity offers a total of 37.25 hours of AOA Category 1A credits and AMA PRA Category 1 Credits™.
Note: ACOI reports credits to the AOA after the end of each quarter.
Learning Objectives:
- Revise and refresh knowledge of core topics in internal medicine and the subspecialties through discussion of common and uncommon clinical problems.
- Apply successful strategies to respond to challenging scenarios.
- Synthesize and implement changes in clinical practice in accordance with recent advances, guidelines, and evidence-based practice.
Release & Review Date:
This activity is valid from July 31, 2024, until July 31, 2027.
-
Contains 6 Component(s), Includes Credits
CME Credit Available: This activity offers 1.25 1A AOA Note: ACOI reports credits to the AOA after the end of each quarter. Learning Objectives: Those participating in this activity will receive information that should allow them to: • Physiology of bladder function and common pathology. • Pharmacology and medication management of the lower urinary tract. • Primary care management of PSA screening for male patients.
CME Credit Available:
This activity offers 1.25 1A AOA
Note: ACOI reports credits to the AOA after the end of each quarter.
Learning Objectives:
Those participating in this activity will receive information that should allow them to:
- Physiology of bladder function and common pathology.
- Pharmacology and medication management of the lower urinary tract.
- Primary care management of PSA screening for male patients.
Conflict of Interest Disclosures:
ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.
Joel Abbott, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.
Release & Review Date:
This activity is valid from July 31, 2024, until July 31, 2027.
Joel Abbott, DO, FACOS
Urologic Surgeon
Pacific West Urology
Dr. Joel Abbott is a board-certified urologist specialized in endourology and minimally invasive surgical techniques, including robotics, laparoscopy and advanced kidney stone care. He completed a specialized Endourology/Laparoscopic fellowship at the University of California, San Diego School of Medicine.Dr. Abbott is primarily focused on management of patients with kidney stones, particularly large/complex kidney stones. He previously served as the associate director of Chesapeake Urology’s Advanced Kidney Stone program and the University of Maryland Clinical Fellowship in Advanced Endourology.He received his medicine degree from Western University of Health Sciences in Pomona, CA and completed his Transitional and General Surgery Internship at West Virginia University, Charleston Area Medical Center. Dr. Abbott completed his residency in Urologic Surgery at Michigan State University, St. John Providence in Detroit, where he served as Chief Resident three consecutive years.Dr. Abbott has received numerous awards and recognitions for his work, including the ACOS Surgeon’s Erwin Literary Award, the MOA Scientific Research Award, the AUA Dr. Edwin L. Thirlby Award, the ACOS Resident Achievement Award, the Mark Cummings, Ph.D. Award for Outstanding Leadership in Medical Scholarship, and the AOF Outstanding Resident of the Year. As a former enlisted active duty Marine, he also earned the Navy and Marine Corps Achievement Medal for professional and leadership achievement.Dr. Abbott’s work has been published in numerous textbooks and prestigious medical journals including the Journal of Urology, Journal of Endourology, Smith’s Textbook of Endourology, and The Canadian Journal of Urology. He has given countless presentations in local, regional, national, and international arenas on his research and work in the minimally invasive treatment of large and complex kidney stones and kidney stone prevention. In addition, he serves as a content reviewer for the Journal of Urology and Urology Practice, Journal of Endourology, and World Journal of Urology.
-
Contains 6 Component(s), Includes Credits
CME Credit Available: This activity offers .75 1A AOA Note: ACOI reports credits to the AOA after the end of each quarter. Learning Objectives: Those participating in this activity will receive information that should allow them to: • Discuss clinical stratification for neurological cases. • Discuss a general overview of multiple sclerosis. • Discuss a general overview of types of strokes.
CME Credit Available:
This activity offers .75 1A AOA
Note: ACOI reports credits to the AOA after the end of each quarter.
Learning Objectives:
Those participating in this activity will receive information that should allow them to:
- Discuss clinical stratification for neurological cases.
- Discuss a general overview of multiple sclerosis.
- Discuss a general overview of types of strokes.
Conflict of Interest Disclosures:
ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.
Scott L. Spradlin, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.
Release & Review Date:
This activity is valid from July 31, 2024, until July 31, 2027.
Scott Spradlin, DO, FACP, FACO
Vice President of Clinical Value and Innovation
Aetna
Vice President Aetna Strategic Clinical and Business Operations
-
Contains 6 Component(s), Includes Credits
CME Credit Available: This activity offers 1.0 1A AOA Note: ACOI reports credits to the AOA after the end of each quarter. Learning Objectives: Those participating in this activity will receive information that should allow them to: • Common skin manifestations of gastrointestinal disease. • Findings and symptoms of cutaneous disease in renal disorders. • Common symptoms of endocrine disorders.
CME Credit Available:
This activity offers 1.0 1A AOA
Note: ACOI reports credits to the AOA after the end of each quarter.
Learning Objectives:
Those participating in this activity will receive information that should allow them to:
- Common skin manifestations of gastrointestinal disease.
- Findings and symptoms of cutaneous disease in renal disorders.
- Common symptoms of endocrine disorders.
Conflict of Interest Disclosures:
ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.
Molly Menser, DO, faculty for this activity, has disclosed the following financial relationships:
- Loreal/Skin Ceuticals-honoraria-speaker
Release & Review Date:
This activity is valid from July 31, 2024, until July 31, 2027.
Molly Menser, DO
Dermatologist/Clinical Preceptor
Kansas City University College of Osteopathic Medicine
Originally from Minnesota, Dr. Molly Menser is a Kansas City-trained board-certified dermatologist that is passionate about the humanistic and whole-person philosophy of patient care and specializes in the integration of skin health, wellness, and beauty. Her formal educational training includes:
Hamline University (St. Paul, MN) – BA, Biology
Kansas City University of Medicine (Kansas City, MO) – Doctor of Osteopathic Medicine
Oklahoma State University / St. Anthony Hospital (Oklahoma City, OK) – Traditional Medicine Internship
University of Kansas Medical Center (Kansas City, KS) – Dermatology Residency
University of Kansas Medical Center (Kansas City, KS) – Chief ResidentWhile completing her training in dermatology, Dr. Menser developed a passion for educating children, adolescents, and adults on the prevention of skin cancer. She is a diplomat of the American Academy of Dermatology (AAD) and an active member of the American Osteopathic College of Dermatology (AOCD), the American Society for Dermatologic Surgery (ASDS), and the American Osteopathic Association (AOA).
In her spare time, Dr. Menser enjoys spending time with her family, reading with her children, traveling, hiking, walking, kayaking, and baking.
-
Contains 6 Component(s), Includes Credits
CME Credit Available: This activity offers .25 1A AOA Note: ACOI reports credits to the AOA after the end of each quarter. Learning Objectives: Those participating in this activity will receive information that should allow them to: • To improve patients' health outcomes by choosing selected diets. • To prevent exacerbations of selected conditions by prescribing appropriate diets. • To educate patients on appropriate diets tailored to their comorbid conditions.
CME Credit Available:
This activity offers .25 1A AOA
Note: ACOI reports credits to the AOA after the end of each quarter.
Learning Objectives:
Those participating in this activity will receive information that should allow them to:
- To improve patients' health outcomes by choosing selected diets.
- To prevent exacerbations of selected conditions by prescribing appropriate diets.
- To educate patients on appropriate diets tailored to their comorbid conditions.
Conflict of Interest Disclosures:
ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.
Robert T. Hasty, DO, FACOI, FACP, faculty for this activity, has no relevant relationships with ineligible companies to disclose.
Release & Review Date:
This activity is valid from July 31, 2024, until July 31, 2027.
Robert T. Hasty, DO, FACOI, FACP
Dean & Chief Academic Officer
Orlando College of Osteopathic Medicine (Proposed)
Dr. Hasty attended the University of Miami where he completed his undergraduate studies with honors as a triple science major in Biochemistry & Molecular Biology, Chemistry and Biology in 1996. He then went on to receive his Doctor of Osteopathic Medicine (DO) at Nova Southeastern University College of Osteopathic Medicine in 2000.
Dr. Hasty had what he described as a “calling” to become an academic physician and joined NSU College of Osteopathic Medicine in March 2005. He served as the Founding Program Director of the Palmetto General Hospital Internal Medicine Residency Program and helped develop several other graduate medical education programs.
In 2013, Dr. Hasty became the Vice President of Medical Education and the Regional Associate Dean and later as Associate Dean for Postgraduate Affairs for Campbell University Jerry M. Wallace School of Osteopathic Medicine in North Carolina. He has served on various boards, including the American College of Osteopathic Internists and the Association of Osteopathic Directors and Medical Educators. Dr. Hasty was the Founding Dean and Chief Academic Officer of the Idaho College of Osteopathic Medicine (ICOM), Idaho’s first medical school.
Dr. Hasty was awarded the 2023 Florida Board of Osteopathic Medicine Morton Morris, DO, JD Award as well as the 2024 Presidential Achievement Award by the Florida Osteopathic Medical Association for the work done creating the Orlando College of Osteopathic Medicine (OCOM).Dr. Hasty currently serves as the Dean & Chief Academic Officer of the Orlando College of Osteopathic Medicine (OCOM) and is the President of the American College of Osteopathic Internists. Dr. Hasty is board certified in internal medicine and is a Fellow of the American College of Osteopathic Internists as well as the American College of Physicians.
-
Contains 6 Component(s), Includes Credits
CME Credit Available: This activity offers .5 1A AOA Note: ACOI reports credits to the AOA after the end of each quarter. Learning Objectives: Those participating in this activity will receive information that should allow them to: • Myopathies and treatments. • Parkinson's, seizures, and motor disorders. • Headaches and treatments.
CME Credit Available:
This activity offers .5 1A AOA
Note: ACOI reports credits to the AOA after the end of each quarter.
Learning Objectives:
Those participating in this activity will receive information that should allow them to:
- Myopathies and treatments.
- Parkinson's, seizures, and motor disorders.
- Headaches and treatments.
Conflict of Interest Disclosures:
ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.
Scott L. Spradlin, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.
Release & Review Date:
This activity is valid from July 31, 2024, until July 31, 2027.
Scott Spradlin, DO, FACP, FACO
Vice President of Clinical Value and Innovation
Aetna
Vice President Aetna Strategic Clinical and Business Operations
-
Contains 6 Component(s), Includes Credits
CME Credit Available: This activity offers .5 1A AOA Note: ACOI reports credits to the AOA after the end of each quarter. Learning Objectives: Those participating in this activity will receive information that should allow them to: • Anticipate selected conditions based upon patients’ genetic disorders. • Correlate genetic inheritance with selected conditions. • Diagnose selected genetic conditions.
CME Credit Available:
This activity offers .5 1A AOA
Note: ACOI reports credits to the AOA after the end of each quarter.
Learning Objectives:
Those participating in this activity will receive information that should allow them to:
- Anticipate selected conditions based upon patients’ genetic disorders.
- Correlate genetic inheritance with selected conditions.
- Diagnose selected genetic conditions.
Conflict of Interest Disclosures:
ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.
Robert T. Hasty, DO, FACOI, FACP, faculty for this activity, has no relevant relationships with ineligible companies to disclose.
Release & Review Date:
This activity is valid from July 31, 2024, until July 31, 2027.
Robert T. Hasty, DO, FACOI, FACP
Dean & Chief Academic Officer
Orlando College of Osteopathic Medicine (Proposed)
Dr. Hasty attended the University of Miami where he completed his undergraduate studies with honors as a triple science major in Biochemistry & Molecular Biology, Chemistry and Biology in 1996. He then went on to receive his Doctor of Osteopathic Medicine (DO) at Nova Southeastern University College of Osteopathic Medicine in 2000.
Dr. Hasty had what he described as a “calling” to become an academic physician and joined NSU College of Osteopathic Medicine in March 2005. He served as the Founding Program Director of the Palmetto General Hospital Internal Medicine Residency Program and helped develop several other graduate medical education programs.
In 2013, Dr. Hasty became the Vice President of Medical Education and the Regional Associate Dean and later as Associate Dean for Postgraduate Affairs for Campbell University Jerry M. Wallace School of Osteopathic Medicine in North Carolina. He has served on various boards, including the American College of Osteopathic Internists and the Association of Osteopathic Directors and Medical Educators. Dr. Hasty was the Founding Dean and Chief Academic Officer of the Idaho College of Osteopathic Medicine (ICOM), Idaho’s first medical school.
Dr. Hasty was awarded the 2023 Florida Board of Osteopathic Medicine Morton Morris, DO, JD Award as well as the 2024 Presidential Achievement Award by the Florida Osteopathic Medical Association for the work done creating the Orlando College of Osteopathic Medicine (OCOM).Dr. Hasty currently serves as the Dean & Chief Academic Officer of the Orlando College of Osteopathic Medicine (OCOM) and is the President of the American College of Osteopathic Internists. Dr. Hasty is board certified in internal medicine and is a Fellow of the American College of Osteopathic Internists as well as the American College of Physicians.
-
Contains 6 Component(s), Includes Credits
CME Credit Available: This activity offers .5 1A AOA Note: ACOI reports credits to the AOA after the end of each quarter. Learning Objectives: Those participating in this activity will receive information that should allow them to: • How to work up and diagnose a polyneuropathy. • How to work up an acute neuropathy. • How to recognize and diagnose a mononeuropathy multiplex.
CME Credit Available:
This activity offers .5 1A AOA
Note: ACOI reports credits to the AOA after the end of each quarter.
Learning Objectives:
Those participating in this activity will receive information that should allow them to:
- How to work up and diagnose a polyneuropathy.
- How to work up an acute neuropathy.
- How to recognize and diagnose a mononeuropathy multiplex.
Conflict of Interest Disclosures:
ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.
Scott L. Spradlin, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.
Release & Review Date:
This activity is valid from July 31, 2024, until July 31, 2027.
Scott Spradlin, DO, FACP, FACO
Vice President of Clinical Value and Innovation
Aetna
Vice President Aetna Strategic Clinical and Business Operations
-
Contains 6 Component(s), Includes Credits
CME Credit Available: This activity offers .5 1A AOA Note: ACOI reports credits to the AOA after the end of each quarter. Learning Objectives: Those participating in this activity will receive information that should allow them to: • Guideline-based treatment for hypertension. • The place of the SPRINT Trial in relation to hypertension treatment goals. • The workup for hypertension.
CME Credit Available:
This activity offers .5 1A AOA
Note: ACOI reports credits to the AOA after the end of each quarter.
Learning Objectives:
Those participating in this activity will receive information that should allow them to:
- Guideline-based treatment for hypertension.
- The place of the SPRINT Trial in relation to hypertension treatment goals.
- The workup for hypertension.
Conflict of Interest Disclosures:
ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.
John E. Prior, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.
Release & Review Date:
This activity is valid from July 31, 2024, until July 31, 2027.
John E. Prior, DO, FACOI
Nephrologist
NEPA Nephrology Associates
Clinical instructor Wright Center for Graduate Medical Education
-
Contains 6 Component(s), Includes Credits
CME Credit Available: This activity offers .5 1A AOA Note: ACOI reports credits to the AOA after the end of each quarter. Learning Objectives: Those participating in this activity will receive information that should allow them to: • The approach to gapped metabolic acidosis. • The use of the urine anion gap. • The diagnosis and treatment approach to metabolic alkalosis.
CME Credit Available:
This activity offers .5 1A AOA
Note: ACOI reports credits to the AOA after the end of each quarter.
Learning Objectives:
Those participating in this activity will receive information that should allow them to:
- The approach to gapped metabolic acidosis.
- The use of the urine anion gap.
- The diagnosis and treatment approach to metabolic alkalosis.
Conflict of Interest Disclosures:
ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.
John E. Prior, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.
Release & Review Date:
This activity is valid from July 31, 2024, until July 31, 2027.
John E. Prior, DO, FACOI
Nephrologist
NEPA Nephrology Associates
Clinical instructor Wright Center for Graduate Medical Education
-
Contains 6 Component(s), Includes Credits
CME Credit Available: This activity offers .5 1A AOA Note: ACOI reports credits to the AOA after the end of each quarter. Learning Objectives: Those participating in this activity will receive information that should allow them to: • The key diagnostic features of Syndrome of inappropriate ADH secretion and appropriate treatments. • The key diagnostic features of central and nephrogenic diabetes insipidus and appropriate treatments. • The key diagnostic features of Gitelman's and Bartter's syndromes.
CME Credit Available:
This activity offers .5 1A AOA
Note: ACOI reports credits to the AOA after the end of each quarter.
Learning Objectives:
Those participating in this activity will receive information that should allow them to:
- The key diagnostic features of Syndrome of inappropriate ADH secretion and appropriate treatments.
- The key diagnostic features of central and nephrogenic diabetes insipidus and appropriate treatments.
- The key diagnostic features of Gitelman's and Bartter's syndromes.
Conflict of Interest Disclosures:
ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.
Mark D. Baldwin, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.
Release & Review Date:
This activity is valid from July 31, 2024, until July 31, 2027.
Mark D. Baldwin, DO, FACOI, FASN (he/him/his)
Professor and Chair, Department of Primary Care Medicine
Arkansas Colleges of Health Education, College of Osteopathic Medicine
